WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.57 Cr | ₹-2.03 Cr | ₹-2.04 Cr | ₹0.68 Cr | ₹-0.66 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WINDLAS BIOTECH ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.57 Cr |
Mar2023 | ₹-2.03 Cr |
Mar2022 | ₹-2.04 Cr |
Mar2021 | ₹0.68 Cr |
Mar2020 | ₹-0.66 Cr |
How is Deferred Tax Assets / Liabilities of WINDLAS BIOTECH Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.57 Cr | Negative | |
Mar2023 | ₹-2.03 Cr | Negative | |
Mar2022 | ₹-2.04 Cr | Negative | |
Mar2021 | ₹0.68 Cr | Positive | |
Mar2020 | ₹-0.66 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of WINDLAS BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WINDLAS BIOTECH | ₹2,032.1 Cr | -3.8% | 4.7% | 92.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹415,697.0 Cr | -2% | -0.8% | 16.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,449.0 Cr | -2.7% | 3.5% | 66.7% | Stock Analytics | |
CIPLA | ₹117,778.0 Cr | 0.7% | 1.4% | 3.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,871.0 Cr | 0.1% | -8.5% | 0.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,046.2 Cr | -0.9% | -1% | 24% | Stock Analytics |
WINDLAS BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WINDLAS BIOTECH | -3.8% |
4.7% |
92.6% |
SENSEX | 0.2% |
-0.1% |
7.2% |
You may also like the below Video Courses